Esophageal Disorders of Peristalsis

Esophageal Disorders of Peristalsis

Yaiel G. Rodríguez-Avilés, MD

Table of Contents

Definition

Definition: A Group of Esophageal Motility Disorders Characterized by Abnormal Esophageal Body Contractions in the Setting of Normal Esophagogastric Junction (EGJ) Relaxation

Disorders are Classified into Two Subcategories

  • Hypomotility Disorders (Reduced Contractile Vigor)
    • Absent Contractility
    • Ineffective Esophageal Motility (IEM)
  • Spastic and Hypercontractile Disorders
    • Distal Esophageal Spasm (DES)
    • Hypercontractile Esophagus

Epidemiology

  • General Prevalence is Poorly Defined – Estimates Vary by Referral Population and Diagnostic Criteria
  • Ineffective Esophageal Motility is Encountered More Frequently than Spastic Disorders

Pathogenesis and Causes

Pathogenesis

  • Normal Esophageal Peristalsis Depends on Coordinated Inhibitory and Excitatory Neural Signaling Within the Myenteric Plexus
    • Inhibitory (Nitrergic) Signaling Produces Smooth Muscle Relaxation
    • Excitatory (Cholinergic) Signaling Promotes Contraction
  • The Relative Balance and Timing of These Pathways Determine the Propagation and Coordination of the Peristaltic Contraction
  • Disruption of This Neural Coordination May Result in Weak, Failed, Premature, or Excessively Vigorous Esophageal Contractions

Causes

  • Primary: Idiopathic
  • Secondary Causes/Associations:
    • Gastroesophageal Reflux Disease (GERD)
    • Connective Tissue Diseases
    • Chronic Opioid Exposure – Especially Spastic Patterns
    • Eosinophilic Esophagitis
    • Other Esophageal Inflammation
    • Neurologic Disorders
    • Diabetes Mellitus
    • Prior Esophageal Surgery or Intervention

Specific Associations

  • Absent Contractility:
    • Often Associated with Connective Tissue Diseases
    • Systemic Sclerosis (Scleroderma) is the Classic and Most Strongly Associated Condition – Smooth Muscle Atrophy and Fibrosis Cause Markedly Reduced or Absent Peristalsis
  • Ineffective Esophageal Motility (IEM):
    • Impaired Neural and/or Smooth Muscle
    • Anticholinergic Medications
    • Often Associated with Severe GERD
  • Distal Esophageal Spasm (DES):
    • Reduced Nitrergic (Nitric Oxide-Mediated) Inhibition Causing Premature Distal Esophageal Contractions
    • Increased Thickness of the Esophageal Smooth Muscle
  • Hypercontractile Esophagus:
    • Excessive Cholinergic Stimulation
    • Failure of Inhibition
    • Uncoordinated Contractions of the Circular and Smooth Muscles
    • Opioid Use Has Also Been Implicated

Clinical Presentation

Clinical Presentation

  • Dysphagia – Most Common Symptom
  • Non-Cardiac Chest Pain
  • Heartburn
  • Regurgitation

Additional Findings

  • Nocturnal Cough
  • Aspiration and Recurrent Pneumonia
  • Hiccups
  • Globus Sensation

Hypomotility Disorders May Be Asymptomatic or Present Predominantly with Reflux Symptoms

Spastic Disorders More Commonly Present with Intermittent Dysphagia and Episodic Non-Cardiac Chest Pain

Diagnosis

Diagnosis

  • High-Resolution Manometry (HRM) is the Diagnostic Gold Standard Test
  • Esophagogastroduodenoscopy (EGD) Should Be Performed in all Patients with Suspected Esophageal Dysmotility to Exclude Mechanical Obstruction or Malignancy
  • Timed Barium Esophagram (TBE) is Complementary but Not Diagnostic of Specific Motility Disorders Itself

Upper Endoscopy/Esophagogastroduodenoscopy (EGD)

  • Often First Diagnostic Test Performed
  • Must Exclude Secondary Mechanical Cause
  • Erosive Esophagitis May Coexist with Disorders of Peristalsis Due to Impaired Esophageal Clearance Causing Prolonged Exposure to Refluxate

High-Resolution Manometry (HRM)

  • The Gold Standard Diagnostic Test
  • Normal Median Integrated Relaxation Pressure (IRP)
  • Abnormal Motor Pattern:
    • Distal Latency (DL): Contraction Timing
    • Distal Contractile Integral (DCI): Contraction Vigor
    • Contractile Pattern: Determines Whether Peristalsis is Intact, Ineffective, Failed, or Hypercontractile
    • *See Classification Below for Specific Findings

Timed Barium Esophagram (TBE)

  • Provides Objective Assessment of Impaired Esophageal Emptying Across the EGJ
  • Rule Out Hernias, Diverticula, and Quantify Emptying

Reflux (pH) Monitoring

  • Selected Patients with Suspected Reflux-Related Symptoms
  • Particularly Useful When Reflux Symptoms Persist Despite Treatment or When the Diagnosis of GERD Is Uncertain

Esophagram Depicting a “Corkscrew”  (Rosary-Bead) Appearance Classically Seen in DES 1

Absent Contractility: Complete Absence of Esophageal Contractions

Ineffective Esophageal Motility (IEM): Frequent Ineffective or Failed Contractions

Distal Esophageal Spasm (DES): Premature Distal Esophageal Contractions with Normal LES Relaxation

Hypercontractile Esophagus: Excessively Vigorous Esophageal Contractions with DCI > 8000

Classification/Types

Based Upon the Chicago Classification – Version 4.0 (CCv4)

Absent Contractility

  • Definition: Complete Absence of Normal Esophageal Body Contraction Despite Preserved EGJ Relaxation
  • Manometry:
    • Normal Median Integrated Relaxation Pressure (IRP)
    • 100% Failed Peristalsis (DCI < 100 mmHg·s·cm)

Ineffective Esophageal Motility (IEM)

  • Definition: Impaired Esophageal Peristalsis Characterized by Weak or Failed Contractions Resulting in Ineffective Bolus Clearance
  • Manometry:
    • Normal Median Integrated Relaxation Pressure (IRP)
    • Either > 70% Ineffective Swallows or ≥ 50% Failed Swallows

Distal Esophageal Spasm (DES)

  • Definition: Premature Esophageal Contraction Timing Despite Preserved EGJ Relaxation
  • Manometry:
    • Normal Median Integrated Relaxation Pressure (IRP)
    • ≥ 20% Premature/Spastic Contractions (DL < 4.5 Seconds) with Normal Vigor (DCI ≥ 450 mmHg·s·cm)
  • A Diagnosis of “Clinically Relevant” DES Requires BOTH:
    • Conclusive Manometry Findings AND
    • Clinically Relevant Symptoms (Dysphagia or Non-Cardiac Chest Pain)

Hypercontractile Esophagus

  • Previously Called “Nutcracker Esophagus” or “Jackhammer Esophagus”
  • Definition: Excessively Vigorous Esophageal Contractions Despite Normal Coordination
  • Manometry:
    • Normal Median Integrated Relaxation Pressure (IRP)
    • ≥ 20% Swallows with DCI > 8,000
  • Subtypes:
    • Single Peak Hypercontractile Swallow – Isolated Excessively Vigorous Contractions
    • Hypercontractile with Jackhammer Esophagus – Repetitive, Prolonged Hypercontractile Contractions
    • Hypercontractile with LES After-Contraction – Hypercontractile Swallow Accompanied by Excessively Vigorous LES After-Contractions
  • A Diagnosis of “Clinically Relevant” Hypercontractile Esophagus Requires BOTH:
    • Conclusive Manometry Findings AND
    • Clinically Relevant Symptoms (Dysphagia or Non-Cardiac Chest Pain)

Note: EGJOO and Spastic Disorders (DES/Hypercontractile Esophagus) Require Specific Symptoms to Be Considered “Clinically Relevant” While Achalasia and Hypomotility Disorders (Absent Contractility/Ineffective Esophageal Motility) Do Not

Treatment

General Management

  • Dietary and Lifestyle Modification:
    • Small, Frequent Meals
    • Eat Slowly and Chew Thoroughly
    • Maintain Adequate Hydration During Meals to Facilitate Esophageal Clearance
    • Identify and Avoid Foods or Beverages that Trigger Symptoms
  • Treat Overlapping GERD/Esophagitis: Proton Pump Inhibitor (PPI)

Reduced Contractile Vigor (IEM/Absent Contractility)

  • Primarily Managed by Dietary and Lifestyle Modification with Optimal Management for Overlapping GERD/Esophagitis
  • Pharmacologic Agents:
    • No Pharmacologic Agent Reliably Restores Contractility
    • IEM: May Consider Prokinetic Agents (Buspirone, Prucalopride, Pyridostigmine, etc) but Evidence of Meaningful Symptomatic Benefit is Limited
    • Absent Contractility: No Established Pharmacologic Therapy
  • Endoscopic Therapy:
    • No Established Endoscopic or Surgical Therapy Restores Esophageal Contractility
    • POEM and Heller Myotomy are Not Indicated

Spastic Disorders (DES/Hypercontractile Esophagus)

  • Pharmacologic Agents: Smooth Muscle Relaxants or Neuromodulators
    • Calcium Channel Blockers
    • Nitrates
    • Low-Dose Tricyclics
  • Endoscopic Therapy:
    • Botulinum Toxin Injection – May Provide Temporary Symptomatic Relief but Limited Durability
    • Pneumatic Dilation – May Be Considered in Selected Patients but Less Well Established than for Achalasia
  • Peroral Endoscopic Myotomy (POEM):
    • Reserved for Severe, Persistent, and Refractory Cases
    • Allows a Longer and More Tailored Myotomy of the Spastic Segment than a Surgical Heller Myotomy
  • Heller Myotomy (HM):
    • May Be Considered in Selected Refractory Patients
    • Largely Fallen Out of Favor and POEM is Generally Preferred for Spastic Motility Disorders

References

  1. Samo S, Carlson DA, Kahrilas PJ, Pandolfino JE. Ineffective Esophageal Motility Progressing into Distal Esophageal Spasm and Then Type III Achalasia. ACG Case Rep J. 2016 Dec 21;3(4):e183. (License: CC BY-NC-ND-4.0)